p53 immunoreaction in hepatocellular carcinoma and its relationship to etiologic factors

Acta Cytologica

Volumn 40, Issue 6, 1996, Pages 1148-1153

  Ojanguren, Isabel ^a   Castellà, Eva ^a   Llatjós, Mariona ^a   Ariza, Aurelio ^a   Palacios, José J Navas ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Aspiration biopsy; Hepatocellular carcinoma; Immunocytochemistry; p53

Indexed keywords

PROTEIN P53;

ALCOHOL ABUSE; ARTICLE; CANCER RISK; CONTROLLED STUDY; HEPATITIS B; HEPATITIS C; HEPATITIS NON A NON B; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RISK FACTOR; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR GENE;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; NON-A, NON-B HEPATITIS VIRUS;

EID: 0030474858     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000333973     Document Type: Article

References (39)

1. Aguilar F, Hussain SP, Cerutti P: Aflatoxin B1 induces the transversion of G to T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci USA 1990;90:8586-8590
2. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, Van Tuinnen P, Ledbetter DH, Barker DF, Nakamura Y, White R, Vogelstein B: Chromosome 17p and p53 gene mutations in colorectal carcinomas. Science 1989;244:217-221
3. Braithwaite AW, Sturzbecher HW, Addison C, Palmer C, Rudge K, Jenkins JR: Mouse p53 inhibits SV40 origindependent DNA replication. Nature 1987;329:458-460
4. Bressac B, Kew M, Wands K, Ozturk M: Selective G to T mutations of p53 gene in hepatocellular carcinoma from Southern Africa. Nature 1991;350:429-431
5. Challen C, Warren W, Guo K, Lunek J, Bassendine MF: A frequent target for genetic abnormalities in human hepatocellular carcinomas in Britain? Hepatology 1991;14:94A
6. Choi SW, Hytiroglou P, Geller SA, Kim SM, Chung KW, Park DH, Theise ND, Thung SN: The expression of p53 antigen in primary malignant epithelial tumors of the liver: An immunohistochemical study. Liver 1993;13:172-176
7. Coursaget P, Depril N, Chabaud M, Nandi R, Mayelo V, Leeann P, Yvonnet B: High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal. Br J Cancer 1993;67:1395-1397
8. Edmonson HA, Steiner PE: Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 1954;7:462-503
9. Fields S, Jang SK: Presence of a potent transcription activating sequence in the p53 protein. Science 1990;249:1046-1049
10. Finaly CA, Hinds OW, Levine AJ: The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989;57:1083-1093
11. Gannon JV, Lane DP: p53 And DNA polymerase alpha compete for binding to SV40 T antigen. Nature 1987;329:456-458
12. Goldblum JR, Bartos RE, Carr KA, Frank TS: Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma. Am J Surg Pathol 1993;17:1244-1251
13. Groopman JD, Busby EWF, Donahue PR: Aflatoxins as risk factors for liver cancer: An application of monoclonal antibodies to monitor human exposure. In Biochemistry and the Molecular Epidemiology of Cancer. Edited by CC Harris. New York, Alan R Liss, 1986, pp 233-256
14. Gusterson BA, Anbazhagan R, Warren W, Midgely C, Lane DP, O'Hare M, Stamps Carter R, Jayatilake H: Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 1991;6:1785-1789
15. Hollstein MC, Metcalf RA, Welsh JA, Montesano R, Harris CC: Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 1990;87:9958-9961
16. Hollstein MC, Sidransky D, Vogelstein B, Harris CC: p53 Mutations in human cancers. Science 1991;253:49-53
17. Hosono S, Chou MJ, Lee CS, Shih C: Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas. Oncogene 1993;8:491-496
18. Hsia CC, Kleiner DE Jr, Axiotis CA, Bisceglie A, Nomura AM, Stemmermann R, Tabor F: Mutations of p53 gene in hepatocellular carcinoma: Roles of hepatitis B virus and aflatoxin contamination in the diet. J Natl Cancer Inst 1992;84:1638-1641
19. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CCI: Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427-428
20. Iggo R, Gatter K, Bartek J, Lane D, Harris AL: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990;335:675-679
21. Isobe M, Emanuel BS, Givol D: Localization of gene for human p53 tumor antigen to band 17p13. Nature 1986; 320:84-85
22. Kress S, Jahn UR, Buchmann A, Bannasch P, Schwartz M: p53 Mutations in human hepatocellular carcinomas from Germany. Cancer Res 1992;52:3220-3223
23. Lane DP, Crawford LV: T antigen is bound to a host protein in SV40-transformed cells. Nature 1979;278:261-263
24. Laurent-Puig P, Flejou JF, Fabre M, Bedossa P, Belghiti J, Gayral F, Franco N: Overexpression of p53: A rare event in a large series of white patients with hepatocellular carcinoma. Hepatology 1992;16:1171-1175
25. Mercer WE, Shields MT, Amin M, Saauve GJ, Apella E, Romano JW, Ullrich SJ: Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 1990;87: 6166-6170
26. Murakami Y, Hayashi K, Hirohashi S, Sekiya T: Aberrations of tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 1991;51:5520-5525
27. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter H, Cleary K, Bigner S, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B: Mutations in the p53 gene occur in diverse human tumor types. Nature 1989; 342:705-708
28. Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenega M, Imura H, Ishizaki K: Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res 1993;53:368-372
29. Nose H, Imazeki F, Ohto M, Omata M: p53 Mutations and 17p allelic deletions in hepatocellular carcinoma from Japan. Cancer 1993;72:355-360
30. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirobashi S: p53 Gene mutation spectrum in hepatocellular carcinoma. Cancer Res 1992;52:6358-6364
31. Prosser J, Thompson AM, Granston G, Evans HJ: Evidence that p53 behaves as a tumor suppressor gene in sporadic breast tumors. Oncogene 1990;5:1573-1579
32. Puisieux A, Lim S, Groopman J, Ozturk M: Selective targeting of p53 mutational hotspots in human cancers by etiologically defined carcinomas. J Cancer Res 1991;51: 6185-6189
33. Raycroft L, Wu H, Lozano G: Transcriptional activation by wild-type but not transforming mutants of the p53 antioncogene. Science 1990;249:1049-1051
34. Robinson WS, Klote L, Aoki N: Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma. J Med Virol 1990;31:12-32
35. Rodrigues NR, Rowan A, Smith MEF, Jerr IB, Bodmer WF, Gannon JV, Lane DP: p53 Mutations in colorectal cancer. Proc Natl Acad Sci USA 1990;87:7555-7559
36. Shie YS, Nguyen C, Vocal MV, Chu HW: Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma. Int J Cancer 1993;54:558-562
37. Slagle BL, Zhou YZ, Butel JS: Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly detected in virus-positive hepatocellular carcinomas. Cancer Res 1991; 51:49-54
38. Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K, Maeda S: p53 Gene abnormalities are closely related to he-patoviral infections and occur at a late stage of hepatocar-cinogenesis. Cancer Res 1994; 54:231-235
39. Vojttesek B, Bartek J, Midgely CA, Lane DP: An immunochemical analysis of the human nuclear phosphoprotein p53. J Immunol Meth 1992;151:237-244